Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Patient Engagement A Key Part Of PCORI’s “Tier 1” Grants

Executive Summary

NEW YORK – Although the list of topics to be researched with “tier 1” grants from the Patient-Centered Outcomes Research Institute will not be finalized until sometime in June, one area that is sure to garner funding opportunities will be finding ways to engage patients as stakeholders.

You may also be interested in...



PCORI Receives More Than 850 Applications For 40 Pilot Project Grants

Grants will help inform Methodology Committee activities; member Clyde Yancy sees committee’s work as setting the bar for how to conduct patient-centered outcomes research.

Physicians Still Concerned PCORI Will Investigate Cost-Effectiveness

Despite a carefully worded statute aimed at keeping cost-effectiveness research out of the work conducted by the Patient-Centered Outcomes Research Institute, the American Medical Association is still concerned that cost could play a role in the institute’s work.

Physicians Still Concerned PCORI Will Investigate Cost-Effectiveness

Despite a carefully worded statute aimed at keeping cost-effectiveness research out of the work conducted by the Patient-Centered Outcomes Research Institute, the American Medical Association is still concerned that cost could play a role in the institute’s work.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS053426

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel